NIMG-54. DIFFUSION MRI PHENOTYPES PREDICT OVERALL SURVIVAL BENEFIT FROM BEVACIZUMAB IN RECURRENT GLIOBLASTOMA WITH A LARGE TUMOR BURDEN: EVIDENCE FROM CLINICAL PRACTICE AND A MULTICENTER PHASE 3 TRIAL

We have previously shown that diffusion MR characteristics are a predictive imaging biomarker for survival benefit in recurrent glioblastoma treated with anti-VEGF therapy; however, contemporary clinical use of bevacizumab is often limited to patients with very large tumors and/or after multiple rec...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Patel, Kunal, Raymond, Catalina, Yao, Jingwen, Tsung, Joseph, Goldman, Jodi, Schlossman, Jacob, Tran, Caleb, Brenner, Andrew, Butowski, Nicholas, Wen, Patrick, Pope, Whitney, Ji, Matthew, Lai, Albert, Leia Nghiemphu, P, Rachmilewitz Minei, Tamar, Cohen, Yael, Harats, Dror, Cloughesy, Timothy, Ellingson, Benjamin
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Neuro-Imaging
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847534/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.723
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars